T1	Concept 0 8	SARS-CoV
T2	Action 33 39	depend
T3	Concept 48 61	extracellular
T4	Concept 66 79	intracellular
T5	Concept 80 85	Ca 2+
T6	Concept 86 91	pools
T7	Concept 107 116	infection
T8	Concept 96 106	successful
R1	has-property Arg1:T7 Arg2:T8	
R2	subject Arg1:T2 Arg2:T1	
R3	in-context Arg1:T6 Arg2:T5	
R4	in-context Arg1:T3 Arg2:T6	
R5	in-context Arg1:T4 Arg2:T6	
R6	target Arg1:T2 Arg2:T3	
R7	target Arg1:T2 Arg2:T4	
R8	in-time Arg1:T2 Arg2:T7	
T9	Concept 168 173	Ca 2+
T10	Action 174 186	interactions
T11	Concept 205 207	FP
T12	Concept 196 204	SARS-CoV
R9	has-part Arg1:T12 Arg2:T11	
R10	subject Arg1:T10 Arg2:T9	
R11	target Arg1:T10 Arg2:T11	
A1	Uncertain T10
R12	entails Arg1:T10 Arg2:T2	
T13	Concept 252 260	facemask
T14	Action 261 268	wearing
T15	Concept 302 316	cost-effective
T16	Concept 371 381	SARS-CoV-2
T17	Concept 321 330	important
R13	target Arg1:T14 Arg2:T13	
A2	Uncertain T14
T18	Action 355 367	transmission
T19	Action 343 350	prevent
R14	target Arg1:T18 Arg2:T16	
R15	target Arg1:T19 Arg2:T18	
R16	has-property Arg1:T14 Arg2:T15	
R18	in-context Arg1:T14 Arg2:T19	
T20	Action 487 497	activation
T21	Concept 505 520	interferon-MAPK
T22	Concept 531 538	pathway
T23	Concept 521 530	signaling
R17	has-property Arg1:T22 Arg2:T23	
R19	in-context Arg1:T22 Arg2:T21	
R20	target Arg1:T20 Arg2:T22	
T24	Concept 543 546	TCR
T25	Concept 551 554	BCR
T26	Action 554 562	produced
T27	Concept 563 573	antibodies
R21	subject Arg1:T26 Arg2:T24	
R22	subject Arg1:T26 Arg2:T25	
R23	target Arg1:T26 Arg2:T27	
T28	Concept 602 612	SARS-CoV-2
T29	Concept 613 622	infection
R24	in-context Arg1:T29 Arg2:T28	
T30	Action 592 601	combating
R25	target Arg1:T30 Arg2:T29	
R26	subject Arg1:T30 Arg2:T27	
R27	subject Arg1:T30 Arg2:T20	
A3	Emphasized T30
T31	Concept 689 697	official
T32	Concept 698 702	data
T33	Action 710 719	diffusion
T34	Concept 723 733	SARS-CoV-2
T35	Concept 774 782	COIVD-19
R28	causes Arg1:T34 Arg2:T35	
R29	has-property Arg1:T32 Arg2:T31	
T36	Action 816 822	suffer
A4	Emphasized T36
A5	Uncertain T36
T37	Concept 837 845	downward
T38	Concept 846 850	bias
R30	has-property Arg1:T38 Arg2:T37	
R31	target Arg1:T36 Arg2:T38	
R32	target Arg1:T33 Arg2:T34	
R33	in-context Arg1:T32 Arg2:T33	
R34	subject Arg1:T36 Arg2:T32	
T39	Concept 855 865	antibodies
T40	Concept 869 879	SARS-CoV-2
T41	Concept 884 892	specific
T42	Concept 894 903	sensitive
T43	Action 933 942	detection
T44	Concept 955 961	faster
T45	Concept 966 973	simpler
T46	Concept 979 985	RT-PCR
R35	in-context Arg1:T39 Arg2:T40	
R36	has-property Arg1:T39 Arg2:T41	
R37	has-property Arg1:T39 Arg2:T42	
R38	subject Arg1:T43 Arg2:T39	
R39	has-property Arg1:T43 Arg2:T44	
R40	has-property Arg1:T43 Arg2:T45	
R41	in-context Arg1:T44 Arg2:T46	
R42	in-context Arg1:T45 Arg2:T46	
T47	Action 1006 1015	screening
T48	Concept 1027 1032	cases
T49	Concept 1019 1026	suspect
R43	has-property Arg1:T48 Arg2:T49	
T50	Concept 1000 1005	rapid
R44	has-property Arg1:T47 Arg2:T50	
R45	entails Arg1:T43 Arg2:T47	
R46	target Arg1:T47 Arg2:T48	
